Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-09

Clinical Trial Update: Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation [Phase 4]

View source ↗

Summary

Phase 4 trial update on antithrombotic therapy in patients with atrial fibrillation after successful ablation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Korea University Guro Hospital | Conditions: Atrial Fibrillation | Phase 4 | Status: TERMINATED